Project Details
Short title | A Phase 2, Multicenter Study of the Effect of the Addition of SNDX-275 to Continued Aromatase (AI) Inhibitor Therapy in Postmenopausal Women with ER+ Breast Cancer Whose Disease is Progressing |
---|---|
Status | Finished |
Effective start/end date | 15/09/08 → 14/09/11 |
Funding
- Queen Elizabeth Hospital Birmingham